Technology | Mammography | September 05, 2017

FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression

New option allows patients to increase or decrease amount of compression applied to their own breast

FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression

September 5, 2017 — The U.S. Food and Drug Administration (FDA) cleared the Senographe Pristina Dueta, a remote control device for GE Healthcare’s Senographe Pristina mammography system that allows patient self-compression. The device makes Senographe Pristina the first 2-D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before the mammogram X-ray is taken.

"Regular mammograms are an important tool in detecting breast cancer," said Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health at the FDA’s Center for Devices and Radiological Health. "However, some patients may experience anxiety or stress about the discomfort from the compression during the mammogram. This device allows patients some control over the amount of compression for their exam."

Mammograms can help detect breast cancer when it is in its early, most treatable stages. A conventional mammogram is a low-dose 2-D X-ray picture of the breast. Digital mammograms use a computer along with X-rays to make and show breast pictures, which are taken in the same way as a conventional mammogram. The resulting breast images are evaluated by a physician qualified under the Mammography Quality Standards Act (MQSA) to identify any abnormalities that might warrant additional work-up.

The Senographe Pristina with Self-Compression via Dueta is a digital mammography system designed to give the patient an active role in the application of compression. During a mammography exam, the technologist positions the patient and initiates compression. The technologist then guides the patient to gradually increase compression using the Senographe Pristina Dueta remote control until adequate compression is reached. The technologist checks the applied compression and breast positioning and makes the final decision on whether the compression is adequate or needs to be adjusted.

The Senographe Pristina with Self-Compression was reviewed through the premarket notification 510(k) pathway. The FDA determined that the system is substantially equivalent to the predicate device Senographe Pristina. A clinical validation demonstrated that the addition of a remote to allow self-compression did not negatively impact image quality. Additionally, performing a mammogram with patient-assisted compression compared to compression solely applied by the technologist did not significantly increase the time of the exam. 

See a demonstration of the self-compression technology in the VIDEO "Editor’s Choice of Most Innovative New Technologies at RSNA 2016."

Read related about related breast imaging technology advances with article links at "New Technology and Clinical Data in Breast Imaging."

For more information: www.gehealthcare.com

Related Content

Sponsored Content | Videos | Pediatric Imaging | February 22, 2018
FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM SonoSite Inc., are offering a full-suite pediatric solutions...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.
Barco Highlights Imaging Workflow Compliance at HIMSS18
News | Flat Panel Displays | February 21, 2018
Barco will showcase its full line of radiology and mammography display systems with online quality assurance (QA)...
DenseBreast-info.org Launches European-Focused Education Coalition
News | Breast Density | February 19, 2018
DenseBreast-info.org (DB-I) announced plans for international expansion with specialized content for Europe and...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Sponsored Content | Videos | Imaging | February 15, 2018
David Widmann, president and CEO of Konica Minolta, looks at what the future of healthcare can bring to its customers,...
Sponsored Content | Videos | Artificial Intelligence | February 15, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
Videos | Enterprise Imaging | February 13, 2018
ITN Contributing Editor Greg Freiherr offers an overview of enterprise imaging advances at the Radiological Society of...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
Overlay Init